Scripps Laboratories
Private Company
Funding information not available
Overview
Scripps Laboratories is a specialized reagent and component supplier serving the global diagnostics and research industries. With a nearly 50-year history, the company has built a deep catalog of purified antigens, monoclonal and polyclonal antibodies, and assay optimization reagents critical for developing and manufacturing immunoassays. Its business model is focused on providing essential raw materials to diagnostic kit manufacturers and research institutions, positioning it as a stable, revenue-generating B2B player in the broader biotech ecosystem. The company operates as a private entity with a lean operational footprint.
Technology Platform
Mastery of classical protein biochemistry and immunology for the commercial-scale production and characterization of purified proteins (antigens), monoclonal/polyclonal antibodies, and specialized assay reagents for immunoassay development.
Opportunities
Risk Factors
Competitive Landscape
Scripps operates in a crowded and competitive niche, competing against giant diversified life science suppliers (e.g., Thermo Fisher Scientific, Abcam, Merck Millipore) and numerous smaller specialty reagent companies. Its competitive edge is derived from nearly 50 years of specialized expertise, a focused catalog on clinical diagnostics, and a reputation for high-quality, consistent products.